(Q77933487)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10385641%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

title

Ursodeoxycholic acid inhibits eosinophil degranulation in patients with primary biliary cirrhosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10385641%20AND%20SRC:MED&resulttype=core&format=json

primary biliary cholangitis

9 December 2019

main subject

0 references

author name string

Yamazaki K

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10385641%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

Suzuki K

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10385641%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

Nakamura A

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10385641%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

Sato S

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10385641%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

Lindor KD

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10385641%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

Batts KP

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10385641%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

Tarara JE

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10385641%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

Kephart GM

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10385641%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

Kita H

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10385641%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

Gleich GJ

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10385641%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

language of work or name

English

0 references

publication date

1 July 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10385641%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10385641%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

volume

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10385641%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10385641%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

page(s)

71-78

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10385641%20AND%20SRC:MED&resulttype=core&format=json

Epithelial injury by human eosinophils

9 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300121

7 January 2021

Eosinophil major basic protein increases membrane permeability in mammalian urinary bladder epithelium.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300121

7 January 2021

Monitoring of asthma inflammation by serum measurements of eosinophil cationic protein (ECP). A new clinical approach to asthma management

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300121

7 January 2021

Primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300121

7 January 2021

Primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300121

7 January 2021

The role of T cells in primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300121

7 January 2021

Eosinophilic infiltration of the liver in primary biliary cirrhosis: a morphological study

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300121

7 January 2021

Elevations in IFN-gamma, IL-5, and IL-10 in patients with the autoimmune disease primary biliary cirrhosis: association with autoantibodies and soluble CD30.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300121

7 January 2021

Raised histamine concentrations in chronic cholestatic liver disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300121

7 January 2021

Ursodeoxycholic acid in primary biliary cirrhosis.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300121

7 January 2021

Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300121

7 January 2021

Ursodeoxycholic acid in the treatment of cholesterol cholelithiasis. part I

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300121

7 January 2021

Hepatoprotective properties of ursodeoxycholic acid

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300121

7 January 2021

Immunomodulatory effects of ursodeoxycholic acid on immune responses

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300121

7 January 2021

Ursodeoxycholic acid corrects defective natural killer activity by inhibiting prostaglandin E2 production in primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300121

7 January 2021

Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis)

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300121

7 January 2021

Ursodeoxycholic acid in the treatment of primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300121

7 January 2021

Analysis of pregnancy-associated major basic protein levels throughout gestation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300121

7 January 2021

Measurement of eosinophil cationic protein (ECP) and eosinophil protein X/eosinophil derived neurotoxin (EPX/EDN). Time and temperature dependent spontaneous release in vitro demands standardized sample processing

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300121

7 January 2021

Identification by immunofluorescence of eosinophil granule major basic protein in lung tissues of patients with bronchial asthma

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300121

7 January 2021

Localization of Eosinophil Granule Major Basic Protein in Chronic Urticaria

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300121

7 January 2021

Monoclonal antibodies distinguish between storage and secreted forms of eosinophil cationic protein

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300121

7 January 2021

Erroneous immunohistochemical application of monoclonal antibody EG2 to detect cellular activation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300121

7 January 2021

Monoclonal antibody EG2 does not provide reliable immunohistochemical discrimination between resting and activated eosinophils

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300121

7 January 2021

Pretreatment with antibody to eosinophil major basic protein prevents hyperresponsiveness by protecting neuronal M2 muscarinic receptors in antigen-challenged guinea pigs.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300121

7 January 2021

In vivo neutralization of eosinophil-derived major basic protein inhibits antigen-induced bronchial hyperreactivity in sensitized guinea pigs

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300121

7 January 2021

Interleukin-5 and its receptor system: implications in the immune system and inflammation.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300121

7 January 2021

Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300121

7 January 2021

New concepts about the mast cell

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300121

7 January 2021

Activation of mast cells by bile acids

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300121

7 January 2021

Interleukin-4, -5, and -6 and tumor necrosis factor-alpha in normal and asthmatic airways: evidence for the human mast cell as a source of these cytokines

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300121

7 January 2021

The effects of glucocorticoids on human eosinophils

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300121

7 January 2021

Marked eosinophilia in a patient with primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300121

7 January 2021

Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300121

7 January 2021

Histological changes of the liver in experimental graft-versus-host disease across minor histocompatibility barriers. VIII. Role of eosinophil infiltration

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300121

7 January 2021

Pharmacology of ursodeoxycholic acid, an enterohepatic drug.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300121

7 January 2021

Identifiers

DOI

10.1002/HEP.510300121

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10385641%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

1 reference